BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19953016)

  • 21. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
    Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
    Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Fire: Superior Vena Cava Syndrome.
    Zimmerman S; Davis M
    Emerg Med Clin North Am; 2018 Aug; 36(3):577-584. PubMed ID: 30037444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
    García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute superior vena cava occlusion after stenting of tracheoesophageal fistula.
    Kapadia MR; de Hoyos AL; Blum MG
    Ann Thorac Surg; 2009 Apr; 87(4):1260-2. PubMed ID: 19324164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stenting in obstruction of superior vena cava; clinical experience with the self-expanding endovascular prosthesis].
    Kanzaki M; Sakuraba M; Kuwata H; Ikeda T; Oyama K; Mae M; Murasugi M; Miyano H; Wachi N; Kikkawa T; Aoshima H; Onuki T
    Kyobu Geka; 2004 May; 57(5):347-50; discussion 350-2. PubMed ID: 15151030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
    Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
    J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gianturco expandable metallic stents in the treatment of superior vena cava syndrome caused by lung cancer].
    Morita R; Akaogi E; Mitsui K; Kuramoto K; Onizuka M; Ishikawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1110-5. PubMed ID: 1324377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac tamponade after malignant superior vena cava stenting: Two case reports and brief review of the literature.
    Da Ines D; Chabrot P; Motreff P; Alfidja A; Cassagnes L; Filaire M; Garcier JM; Boyer L
    Acta Radiol; 2010 Apr; 51(3):256-9. PubMed ID: 20201637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation.
    Xiao L; Li Z; Wu L; Sun Z; Yu X
    Technol Cancer Res Treat; 2009 Aug; 8(4):281-7. PubMed ID: 19645521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioactive Seed Strand Efficacy in Superior Vena Cava Stenting Due to Non-small-cell Lung Cancer Obstruction.
    Yuan FK; Fu YF; Shi YB; Yang N
    Vasc Endovascular Surg; 2022 Feb; 56(2):173-179. PubMed ID: 34704875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Superior vena cava syndrome successfully controlled by metallic stent insertion].
    Sakaguchi Y; Kono T; Terada Y; Noda H
    Kyobu Geka; 2009 Jun; 62(6):460-3. PubMed ID: 19522205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign superior vena cava syndrome: stenting is now the first line of treatment.
    Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
    J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
    Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
    Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malignant superior vena cava syndrome: why refrain from vascular stenting?].
    Greillier L; Vidal V; Barlési F
    Rev Mal Respir; 2009 Sep; 26(7):719-21. PubMed ID: 19953012
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and Efficacy of Stent Graft Implantation for Malignant Superior Vena Cava Syndrome.
    Cao S; Zou Y; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J
    Heart Surg Forum; 2021 Nov; 24(6):E952-E957. PubMed ID: 34962478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of endovascular stent placement in the superior caval venous system.
    Smayra T; Otal P; Chabbert V; Chemla P; Romero M; Joffre F; Rousseau H
    Cardiovasc Intervent Radiol; 2001; 24(6):388-94. PubMed ID: 11907745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of metallic stents in the treatment of malignant superior vena caval obstruction.
    Tan BS; Htoo MM; Yeong KY
    Ann Acad Med Singap; 1995 Mar; 24(2):198-203. PubMed ID: 7544558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expandable Wallstent for the treatment of obstruction of the superior vena cava.
    Watkinson AF; Hansell DM
    Thorax; 1993 Sep; 48(9):915-20. PubMed ID: 7694384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endovascular stenting in superior vena cava syndrome: utility of a through-and-through guidewire technique.
    Clark TW
    Can Assoc Radiol J; 2000 Aug; 51(4):254-9. PubMed ID: 10976248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.
    Stock KW; Jacob AL; Proske M; Bolliger CT; Rochlitz C; Steinbrich W
    Thorax; 1995 Nov; 50(11):1151-6. PubMed ID: 8553270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.